INTELLIGENT BIO SOLUTIONS INC. current report, 27 April 2022

Business Context and Reporting Period

This Form 8-K is a current report filed by GBS Inc. (trading symbol: GBS) on April 29, 2022, regarding an event that occurred on April 27, 2022. The registrant is incorporated in Delaware and its common stock is listed on The NASDAQ Stock Market LLC. The filing identifies the company as an emerging growth company.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.

Material Changes

The primary material change reported is the resignation of Leon Kempler as a member of the Board of Directors, effective April 27, 2022. Mr. Kempler was not a member of any Board committees. The Company explicitly states that the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are disclosed beyond the standard disclosure of the director's departure.

Investor Verification Checklist

  • Verify the current composition of the Board of Directors following Mr. Kempler's resignation.
  • Confirm whether a successor director has been appointed to fill the vacancy.
  • Review recent 10-K or 10-Q filings for the most up-to-date financial metrics, as this 8-K does not contain them.